Ranked #2,522 of 8,699 institutional investors
Samsara Biocapital, LLC
Palo Alto, CA
$893M
US stock portfolio at live prices · today −$11.3M (−1.24%)
Live prices, last trade 11:43 AM ET
- Value at quarter end (Q3 2026)
- $1.05B
- Change from Q2 2026
- −$165.9M (−13.62%)
- Positions
- 26 · 2 new, 0 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$1.3M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSRRK 39.2%SEPN 13.5%MLYS 9.21%ALMR 7.50%SGP 7.26%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SRRK Scholar Rock Holding Corporation | 6,897,652 | $350M | 39.2% | Unchanged |
| SEPN Septerna, Inc. | 3,066,453 | $120M | 13.5% | Reduced −3% |
| MLYS Mineralys Therapeutics, Inc. | 5,871,018 | $82.3M | 9.21% | Unchanged |
| ALMR Alamar Biosciences, Inc. | 2,480,310 | $67.0M | 7.50% | Unchanged |
| SGP SpyGlass Pharma, Inc. | 2,109,953 | $64.8M | 7.26% | Unchanged |
| NGNE Neurogene Inc. | 1,867,127 | $42.3M | 4.74% | Added +9% |
| ALMS Alumis Inc. | 7,235,809 | $29.6M | 3.31% | Added +14% |
| IVA Inventiva S.A. | 6,314,805 | $20.6M | 2.31% | Unchanged |
| KLRS Kalaris Therapeutics, Inc. | 12,881,175 | $17.3M | 1.94% | Unchanged |
| PBLS Parabilis Medicines, Inc. | 556,044 | $15.5M | 1.74% | Unchanged |
| JBIO Jade Biosciences, Inc. | 736,237 | $11.3M | 1.26% | Unchanged |
| OBX Obsidian Therapeutics, Inc. | 837,173 | $10.0M | 1.12% | New |
| STRO Sutro Biopharma, Inc. | 1,062,872 | $9.3M | 1.04% | Unchanged |
| AQST Aquestive Therapeutics, Inc. | 2,434,367 | $8.6M | 0.96% | Reduced −3% |
| VTVT vTv Therapeutics Inc. | 354,730 | $5.8M | 0.65% | Added +19% |
| RANI Rani Therapeutics Holdings, Inc. | 10,369,159 | $5.8M | 0.65% | Unchanged |
| PMVP PMV Pharmaceuticals, Inc. | 7,240,000 | $5.4M | 0.61% | New |
| ELOX Eloxx Pharmaceuticals, Inc. | 400,000 | $4.3M | 0.48% | Unchanged |
| NKTX Nkarta, Inc. | 3,507,666 | $4.1M | 0.46% | Unchanged |
| XFOR X4 Pharmaceuticals, Inc. | 1,347,723 | $4.0M | 0.45% | Reduced −3% |
| ABVX ABIVAX Société Anonyme | 55,095 | $3.8M | 0.43% | Unchanged |
| ARTV Artiva Biotherapeutics, Inc. | 954,861 | $3.7M | 0.41% | Unchanged |
| AGMB AgomAb Therapeutics NV | 594,749 | $3.4M | 0.38% | Reduced −1% |
| CHRS Coherus Oncology, Inc. | 3,383,565 | $1.3M | 0.15% | Reduced −1% |
| GOSS Gossamer Bio, Inc. | 87,956 | $991K | 0.11% | Reduced −3% |
| UPB Upstream Bio, Inc. | 300,361 | $547K | <0.1% | Reduced −15% |